Caitlin Costello, MD, discusses the role and safety of bispecific antibodies approved for the treatment of relapsed/refractory multiple myeloma as well as emerging data and clinical trials with this treatment approach.

Listen as Thor R. Halfdanarson, MD, and Jonathan Strosberg, MD, discuss the diagnosis and typical presenting symptoms of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) as well as findings from recent phase III studies including NETTER-2 and CABINET. Notable clinical pearls regarding...

Audio podcast with key clinical highlights for gynecologic cancers from the 2024 ESMO congress. Listen to experts put new trial results into context and share their perspectives and takeaway points for integrating new data into your everyday practice.